| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2. D. Chu, T.H. Chan and B.A. Kovacs: Isolation of an antihistamine substance from the oak gall. Fed. Proc., vol. 29 No. 2
(1970)
3. Chu D., Chan T.H., Rose B and Kovacs, B.A.: Antihistaminic and anti-inflammatory activity of a substance newly isolated from
oak galls. Excerpta Medica, International Congress Series No. 211 (1970)
4. Chu D, Cocco G, Leishman B: New calcium antagonists in clinical research. Buenos Aires Meeting on Calcium Antagonists,
Dec. 4-6. 1980.
5. D. Chu: Isolation of Biologically Active Substances from Oak Galls exerting Antihistamine and Anti-Inflammatory Activity.
PhD Thesis, McGill University, Montreal, P.Q., Canada (1972)
6. D. Chu and E. Stürmer: Studies on the mechanism of action of dihydroergotamine (DHE) on the vascular bed of cat skeletal
muscle. Br. J. Pharmac. 48 : 331P (1973)
7. D. Chu, R. Gregeen and E. Stürmer: Actions of PGA2, PGE1 and PGF2α on cat skeletal muscle vascular bed. Br. J. Pharmac.
52 : 112P – 113P (1974)
8. D. Chu : Effects of prostaglandins (PGs) on cat mesenteric vasculature. Presented at First World Congress for
Microcirculation, Toronto, Canada, 15 – 20. 06. 1975
9. D. Chu, A. Hofmann and E. Stürmer: A method for screening of antihypertensive agents in normotensive rats.
Naunyn-Schmiedeberg’s Archives of Pharmacology, 287, R 18 (1975)
10. D. Chu and B. Hool-Zulauf: Studies on the reserpine-induced potentiation of the peripheral vascular effect of DHE in cats.
Naunyn-Schmiedeberg’s Archives of Pharmacology, 287, R 22 (1975)
11. C. Strozzi (Italy), G. Cocco and D. Chu: The kinetocardiogram and dopamine in the assessment of coronary heart disease.
Current Therapeutic Research, 18, 261-275 (1975)
12. D. Chu, T.H. Chan and B.A. Kovacs: Isolation and chemical identification of a substance exerting antihistamine-like
activity (KC-18). Arch. Int. Pharmacodyn. 214, 141-154 (1975)
13. D. Chu and B.A. Kovacs: Biologically active substance in oak gall extracts. Part II: The Antihistamine-like activity of a
substance (KC-18) isolated from oak gall extracts. Arch. Int. Pharmacodyn., 214, 155-164 (1975)
14. D. Chu, D.A.A. Owen, E. Stürmer: Effects of ergotamine and dihydroergotamine on the resistance and capacitance
vessels of skin and skeletal muscle in the cat. Postgrad. Med. J. 52: 32-36 (1976)
15. G. Cocco, C. Strozzi and D. Chu: Beta-blocking agents were introduced into clinical use 15 years ago – myths
and reality (II). Clinica Terapeutica, V80, N1, P67-89, (1977)
16. D. Chu and B.A. Kovacs: Anti-inflammatory activity in oak gall extracts. Archives Internationales de
Pharmacodynamie et de Thérapie. V230, N1, P 166-176 (1977)
17. G. Cocco, F. Burkart, D. Chu and F. Follath: Intrinsic sympathomimetic activity of beta-adrenoceptor blocking
agents. European Journal of Clinical Pharmacology, V13, N1 P1-4 (1978)
18. Clark B., Chu D. Aellig W.H.: Actions of ergot alkoloids on the heart and circulation, In “Ergot Alkaloids and
Related Compounds” (Eds. B. Berde and H.O. Schild) Handbook of Experimental Pharmacology. Pp 321 – 420
Spring Verlag, Berlin, Heidelberg, New York (1978)
19. D. Chu, A. Hofmann and E. Stürmer: Anesthetized normotensive rats for detection of hypotensive activity of a
beta-adrenoceptor antagonist and other antihypertensive agents. Arzneimittel-Forschung/Drug Research,
V28, N11, P2093-2097 (1978)
20. G. Cocco, C. Strozzi, D. Chu, R. Amrein and E. Castagnoli: Therapeutic effects of pindolol and nifedipine in
patients with stabale angina-pectoris and asymptomatic resting ischemia. European Journal of Cardiology,
V10, N1, p 59-69 (1979)
21. G. Cocco, C. Strozzi, G. Haeusler, D. Chu, R. Amrein and G.C. Padovan: Therapeutic value of clonidine in
patients with coronary heart-disease. European Journal of Cardiology, V10, N3, p 221-228 (1979)
22. R. Salzmann, H. Burki, D. Chu, B. Clark, P. Marbach. R. Markstein, H. Reinert, H. Siegl and R. Waite:
Pharmacological activity of the antihypertensive agent 6-Benzoyl-3-Hydrazino-5,6,7,8-Tetrahydropyrido
(4,3-C*Pyridazine). Arzneimittel-Forschungs/ Drug Research, V29-2, N12, p 1843-1853 (1979)
23. G. Cocco, D. Chu, C. Strozzi: Dimeditiapramine (Ro 11-1781) a new calcium antagonist in the management
of supraventricular tachyarrhythmias in patients with acute myoardial infarction. Clin. Cardiol. 2 : 131-134 (1979)
24. G. Cocco, C. Strozzi, D. Chu: Human electropharmacology of the calcium antagonist dimeditiapramine
(Ro 11-1781) in coronary patients. Clin. Cardiol. 2 : 212 (1979)
25. F. Nowak, G. Cocco, D. Chu and D.F. Gasser: Antiarrhythmic effect of the calcium antagonist tiapamil
(Ro 11-1781) by intravenous administration in patients with coronary heart disease. Clin. Cardiol. 3 : 371-376 (1980)
26. G. Cocco, C. Strozzi, S. Braun and D. Chu: Effecti de tiapamil (un nuovo Ca++ antagonista) suella funzionalita
cardioca. *rd. International Congress of Cardiology, Modena (Italy) (1980)
27. G. Cocco, C. Strozzo, S. Braun and D. Chu: Torsades des Pointes: un’inconsueta forma di cardiotossicita indotta
della mexiletina. 3rd. International Congress of Cardiology Modena (Italy) (1980)
28. D. Chu, G. Cocco, E. Schweda, G. Haeusler and C. Strozzi: Influence of propranolol and pindolol on the hemodynamic-
effects of papavarine, isoprenaline and noradrenaline in hypertensive patients. European Journal of Clinical Pharmacology,
V18, N2, P141-146 (1980)
29. G. Cocco, C. Strozzi, D. Chu and R. Pansini: Torsades-de-pointes as a manifestation of mexiletine toxicity.
American Heart Journal, V100, N6, P878-880 (1980)
30. D. Chu, G. Cocco and C. Strozzi: Antihypertensive effects of a new vasodilator Ro 12-4713 in essential
hypertension. Seventh Scientific Meeting of the International Society of Hypertension, New Orleans, Louisiana (1980
31. D. Chu, G. Cocco, C. Strozzi, R. Vallini, M. Nonato and R. Amrein: Antihypertensive effects of a novel peripheral
vasodilator, Ro 12-4713. European Journal of Clinical Pharmacology, V19, N4, P233-238 (1981)
32. D. Chu, F. Burkart, G. Cocco and M. Gerold: Comparison of hemodynamic-effects of standardized karate exercise
and cycloergometry. Schweizerische Medizinische Wochenschrift, V111, N26, P1020-1023 (1981)
33. Chu D, Burkart F, Cocco G: Wirkung einer standardisierten Karateübung auf den arteriellen Blutdruck und die
Herzfrequenz im Vergleich zur Fahrradergometerübung. Jahresversammlung Schweiz Gesellschaft Intensivmedizin,
Oct. 17-18, 1980; Autoren Referat no. 10.
34. D. Chu, D. Digori: Antihypertensive effects of tiapamil, a calcium antagonist: a double-blind placebo crossover study.
Proceedings of the First International Symposium, Karger, Basel (1981)
35. D. Conen, O. Bertel, D. Chu, F. Bühler and U.C. Dubach: Short-term and long-term effects of a new long-acting
vasodilator (Ro 12-4713) on blood pressure, heart rate, plasma catecholamine, plasma renin activity and aldosterone.
Ninth Scientific Meeting on the International Society of Hypertension, Mexico City, Mexico (1982)
36. D. Chu, G. Cocco and C. Strozzi: Antihypertensive effects of a new vasodilator Ro 12-4713 in essential hypertension.
Seventh Scientific Meeting of the International Society of Hypertension, New Orleans, Louisiana (1980)
37. D. Chu: The Complementary nature of Traditional Chinese Medicine and Conventional Western Medicine in health care.
Die Schweizerische Arzt & Spital Revue, Vol. 6, No. 4, P6 – 8 (2002)
38. Lindvall K, Cocco G, Chu D et al.: Serial M-mode echocardiography in evaluation of the cardiovascular effects of tiapamil
and their relationship to plasma levels in patients with coronary heart disease. Internat J Cardiol 1981; 1:163-71.
39. Cocco G, Chu D et al.: Asymptomatic myocardial ischemia in patients with stable and typical angina pectoris.
Clin Cardiol 1982; 5:403-8.
40. Strozzi C, Cocco G. Chu D et al.: Management of Raynaud's phenomenon with drugs affecting the sympathetic
nervous system: a double blind study. Curr Ther Res 1982; 33:225-35.
41. Cocco G, Chu D et al.: A review of the side effects of ß-adrenoceptor blocking drugs on the skin, mucosae and
connective tissue. Curr Ther Res 1982; 31:362-78.
42. Cocco , Chu D et al.: Antiarrhythmic effect of tiapamil and propranolol assessed from the reduction of ventricular
arrhythmias in the cycloergometer test. A double-blind study. Cardiology 1982; 69 Suppl 1:181-6.
43. Eckert M, Cocco G, Chu D et al.: Relationship between pharmacokinetic and pharmacodynamic behaviour of bufuralol
and its metabolite Ro 3-7410 in hypertensive patients. Eur J Clin Pharmacol 1983; 24: 479-84
44. Cocco G, Chu D et al.: Antiarrhythmic use of cibenzoline, a new class 1 antiarrhythmic agent with class 3 and
4 properties, in patients with recurrent ventricular tachycardia. Eur Heart J 1984; 5:108-14.
45. Cocco G, Chu D et al.: Vasodilator treatment for mild to moderate heart failure. Effect of Ro 12-4713, a minoxidil
analogue. Cardiology 1984; 71:184-9.
46. Cocco G and Chu D: The Anti-Ischemic Effect of Metoprolol in Patients with Chronic Angina Pectoris Is Gender-Specific.
Cardiology 2006; 106:147-53.
47. Cocco G and Chu D: Stress induced cardiomyopathy, a review. Accepted for publication in Eur. J Int. medicine
(2007).
48. Cocco G and Chu D: Weight reduction reduces NT-proBNP levels in patients with chronic diastolic heart failure. Arch Med Sci
2007;2:112-116
 |
 |
||
